Dr. Yuki Nakamura, Japan
Efficacy and safety of early mammalian target of rapamycin inhibitors with minimization of calcineurin inhibitors in kidney transplant recipients
Prof. In Sung Moon, Korea
The outcome of kidney transplant recipients who had combined ABO incompatibility and performed antibody against donor HLA antigen
Dr. Yoji Hyodo, Japan
The new desensitization protocol for ABO incompatible living donor kidney transplantation using low dose rituximab without plasmapheresis
Prof. Raj Kumar Sharma, India
Effect of vitamin D deficiency on antibody-mediated rejection (ABMR): a comparative analysis of live-related ABO-incompatible and abo-compatible renal transplantation
Dr. Georgina Irish, Australia
Screening for urinary chemokines in long term renal transplant patients associates with cellular rejection, microvascular damage and falls in GFR over time
Dr. Esther González Monte Sr., Spain
Kidney transplantation from uncontrolled donation after circulatory death, our outcomes compared to donation after brain death after very long time.
Mrs. Patricia Ramirez, Spain
Functional outcomes of the renal transplants obtained from controlled donation following cardiopulmonary death (DCD) with compartmental normothermic extracorporeal membrane oxygenation support (NECMO)
Prof. Xiao-Peng Yuan, P.R. China
The effect of chronic lesions in implantation biopsy on the function and survival of renal grafts from donation after cardiac death donors
Dr. Miyeun Han, Korea
The short term outcome of deceased donor kidney transplantation with a short cold ischemic time is comparable to that of living donor kidney transplantation
Dr. Susana M. Norton, Portugal
Kidney transplantation from circulatory death donors with abdominal normothermic oxygenated recirculation support: The impact of cold ischemia
Dr. Victoria Gomez Dos Santos, Spain
Perfusion parameters during hypothermic machine perfusion in expanded criteria donors (ECD) and donors after circulatory death (DCD) does comparison allow their categorization?
Miss Moira H. Bruintjes, Netherlands
Double J is superior to externally draining ureteric stent in enhancing recovery after living donor kidney transplantation
Ms. Abeera Ali, Canada
Taking specific steps to pursue living donor kidney transplant is associated with greater odds of receiving a living donor offer
Dr. Engida Abebe Gelan, Ethiopia
Patient characteristics and outcomes following establishment of a living donor kidney transplant program in Sub-Saharan Africa
Dr. Yingxin Fu, P.R. China
Relevance between living donors ‘renal reserve capacity and recipients graft function'-retrospective study of 72 cases of living donor kidney transplantation
Mrs. Snježana Šulc, Croatia
Long-term cancer incidence in kidney transplant recipients in relation to the first posttransplant year immunossuppresion intensity
Dr. Ming-Che Lee, Taiwan
Associations between high serum adipocyte fatty acid binding protein and first hospitalization in kidney transplantation patients
Dr. Joanna Pazik, Poland
Malnutrition in kidney allograft recipients treated with mycophenolate mofetil is associated with IMPDH1 rs2278294 polymorphism.
Dr. Jose Luis Santiago, Spain
Genetic associations of polymorphism located at loci relevant for kidney function in a cohort of kidney transplant recipients
Dr. Lara Belmar Vega, Spain
Relationship between the histological findings obtained by 1-year protocol biopsies and kidney transplant failure score (KTFS)
Dr. Emil Holmström, Finland
The impact of deceased donor simvastatin treatment on kidney transplant outcomes - Results of a double-blinded, randomized controlled trial
Dr. Takeshi Ishimura, Japan
Voiding function of kidney transplanted recipients with bladder capacity abnormality in congenital renal hypoplasia/dysplasia
Dr. Lampros Kousoulas, Germany
Clinical characteristics and outcomes of renal transplant recipients after abdominal surgical procedures not connected with transplantation
Mrs. Ester Casillas Sagrado, Spain
Progression of renal function after treatment with the new antivirals for hepatitis C: Is there a difference between chronic kidney disease and kidney transplant patients?
Fabienne Dobbels, Belgium
Establishing a core outcome measure for life participation: A standardized outcomes in nephrology – kidney transplantation (SONG-Tx)consensus workshop report
Dr. Tomas Reischig, Czech Republic
Impact of viral load in polyoma-BK virus viremia on histologic findings in late protocol biopsy in kidney transplant recipients
Dr. Bryan Christian Gaza Ilagan, Philippines
Panel reactive antibody positivity and associated human leukocyte antigen antibodies in Filipino kidney transplant candidates at the national kidney and transplant institute
Dr. Antonia Alvarez Marquez, Spain
Analysis of kidney transplantation results of very highly sensitized patients included in a virtual crossmatch programme and their kidney pairs. Results of 5 years since the beginning of the protocol. Andalusian group for highly sensitized patients
Dr. Matthew P. Sypek, Australia
Factors associated with time to deceased donor renal transplant waitlisting or living donor transplantation in Australia
Dr. Xiaobing Ju, P.R. China
Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients
Dr. Maria Luisa Rodríguez-Ferrero, Spain
Clinical experience of conversion from antimetabolites with standard exposure tacrolimus to everolimus with tacrolimus minimization in stable kidney transplanted recipients
Dr. Maria Luisa Rodríguez-Ferrero, Spain
Donor specific antibodies after conversion from mycophenolate mofetil with standard exposure tacrolimus to everolimus with tacrolimus minimization in stable kidney transplanted recipients
Dr. Junji Uchida, Japan
Late conversion to everolimus with calcineurin inhibitor minimization in stable kidney transplant recipients - analysis of factors affecting ΔeGFR
Dr. Fatima AlKendi, United Arab Emirates
Exceptional high dose tacrolimus requirement in a twin pregnancy post kidney transplant: Review and case report
Luis Gaite, Argentina
Use of ATG FR in mode of single dose in recipients of renal transplantation. Experience of 2 transplant units of Sante Fe, Argentina
